116308-10-2

Upstream product

• 13096-62-3 (3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-one 
• 140658-49-7 2,3,4,6-Tetra-O-benzyl-1-C--α-D-glucopyranose 

Downstream Products

• 140658-58-8 3,4,5,7-Tetra-O-benzyl-1-deoxy-D-glycero-D-gulo-heptitol 
• 140658-51-1 2,3,4,6-Tetra-O-benzyl-1-C--D-xylo-5-hexosulose 

Relevant academic research and scientific papers

Inosose derivatives, production and use thereof

Disclosed is a novel inosose compound represented by the general formula: STR1 wherein X1 and X2 are both halogen; X1 is hydrogen and X2 is halogen; or X1 is --SQ1 and X2 is --SQ2 (each of Q1 and Q2 is lower alkyl or Q1 and Q2 may form lower alkylene), R1 is a protective group for hydroxyl and Y is =O, =N--Z (Z is hydroxyl which may be protected) or STR2 (A is hydrogen or an amine residue), particularly to the compound wherein the symbol Y is oxygen. The inosose compound is useful as intermediates for production of valiolamine and the N-substituted derivatives thereof, which have potent α-glucosidase inhibiting activities and are useful as preventives or therapeutics for symptoms of hyperglycemia and various diseases derived therefrom in human and animals, such as diabetes, obesity and hyperlipemia.